-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Alvimopan is a synthetic opioid analgesic drug that is used to treat pain.
It is a potent agonist at the mu-opioid receptor, which is responsible for its analgesic effects.
Alvimopan is synthesized through a series of chemical reactions that involve the assembly of several chemical building blocks, or precursors, into the final drug molecule.
One of the earliest steps in the synthesis of alvimopan involves the synthesis of an intermediate compound called oxymorphone.
Oxymorphone is a precursor to many different opioid drugs, including alvimopan.
To synthesize oxymorphone, the starting material is a chemical called morphine, which is a naturally occurring alkaloid found in the opium poppy plant.
The morphine is first converted into a chemical called codeine through a series of chemical reactions.
The codeine is then modified to create oxymorphone through a process called N-demethylation, which involves the removal of a methyl group from the molecule.
Once oxymorphone has been synthesized, it can be further transformed into alvimopan through a series of chemical reactions.
The first step involves the substitution of one of the hydrogen atoms in oxymorphone with a fluorine atom, which is carried out using a chemical called chloramine T.
This reaction causes a shift in the chemical properties of the molecule, making it more reactive and allowing it to undergo the next step in the synthesis.
The next step in the synthesis of alvimopan involves the addition of a methyl group to the molecule, which is carried out using a compound called dimethyl sulfate.
This reaction adds a methyl group to the molecule at a specific location, creating a new chemical group that is essential for the activity of the drug as an opioid agonist.
After the methylation step, the molecule is further modified by the addition of another chemical group, called a benzoxazepine ring.
This ring structure is added to the molecule using a compound called chlordehydroazepine, and it is important for the binding of the drug to the mu-opioid receptor.
Finally, the synthesis of alvimopan is completed by the addition of a final chemical group, called a benzamide group.
This group is added using a compound called N-benzyl morphine, and it is important for the stability and pharmacokinetics of the drug.
Overall, the synthesis of alvimopan involves a series of complex chemical reactions that require a high degree of technical expertise and specialized equipment.
The use of dangerous reagents and hazardous chemicals requires strict safety precautions to be taken, and the entire process must be carefully monitored and controlled to ensure the production of a safe and effective drug product.
Despite these challenges, the synthesis of alvimopan represents an important advance in the development of new opioid drugs for the treatment of pain, and continues to be an active area of research and development in the pharmaceutical industry.